New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a ‘Form 483’ with three observations to its manufacturing facility in Somerset, New Jersey, following a recent inspection.In a regulatory filing, the pharmaceutical company said that the inspection by the US Food and Drug Administration (USFDA) was conducted this week between April 13 and April 17.”The inspection was completed with the issuance of a Form 483 carrying three observations,” th…
Trending
- Phula (2026) Movie Review: A Soulful Tale of Resilience and Folk Art
- Therachaapa Movie Review: A Rooted Rustic Drama Packed With Emotion and Grit
- Salbardi (2026) Review: A Gripping Tale of Mystery and Justice From the Heartland
- Bad Boy Karthik Review (2026): A Brother’s Fight That Packs Enough Heart to Win You Over
- Matka King Review: Vijay Varma’s Finest Hour in a Gripping Bombay Crime Drama
- Pallichattambi Movie Review: Tovino Thomas Leads a Powerful Period Drama with Mass Appeal
- Mr X Movie Review: Stylish Spy Action Thriller Delivers Big-Screen Entertainment with Arya in Command
- Thimmarajupalli TV Movie Review: A Heartwarming Nostalgia Trip That Captures the Soul of Rural Telugu Cinema